- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 11/00 - Drugs for disorders of the respiratory system
Patent holdings for IPC class A61P 11/00
Total number of patents in this class: 11342
10-year publication summary
|
324
|
599
|
622
|
721
|
1216
|
1043
|
1158
|
765
|
760
|
413
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mondobiotech Laboratories AG | 311 |
289 |
| Chiesi Farmaceutici S.p.A. | 960 |
174 |
| Boehringer Ingelheim International GmbH | 4487 |
153 |
| AstraZeneca AB | 2820 |
123 |
| Vertex Pharmaceuticals Incorporated | 1579 |
119 |
| Novartis AG | 10224 |
92 |
| Daiichi Sankyo Company, Limited | 1890 |
69 |
| F. Hoffmann-La Roche AG | 7816 |
64 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3331 |
59 |
| The Regents of the University of California | 20790 |
56 |
| Genentech, Inc. | 4113 |
55 |
| Bristol-myers Squibb Company | 4747 |
54 |
| Glaxosmithkline Intellectual Property Development Limited | 779 |
52 |
| Takeda Pharmaceutical Company Limited | 2713 |
52 |
| Bayer AG | 3504 |
42 |
| Theravance Biopharma R&D IP, LLC | 360 |
42 |
| Bayer Pharma AG | 1009 |
41 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3314 |
41 |
| Centre National de La Recherche Scientifique | 11042 |
39 |
| Board of Regents, The University of Texas System | 6127 |
37 |
| Other owners | 9689 |